Edinburgh Research Explorer

A decoy receptor 3 analogue reduces localised defects in phagocyte function in pneumococcal pneumonia

Research output: Contribution to journalArticle

Related Edinburgh Organisations

Open Access permissions

Open

Documents

  • Download as Adobe PDF

    Rights statement: This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode.

    Final published version, 190 KB, PDF document

    Licence: Creative Commons: Attribution Non-Commercial (CC-BY-NC)

http://thorax.bmj.com/content/67/11/985
Original languageEnglish
Pages (from-to)985-992
Number of pages8
JournalThorax
Volume67
Issue number11
DOIs
Publication statusPublished - Nov 2012

Abstract

Background Therapeutic strategies to modulate the host response to bacterial pneumonia are needed to improve outcomes during community-acquired pneumonia. This study used mice with impaired Fas signalling to examine susceptibility to pneumococcal pneumonia and decoy receptor 3 analogue (DcR3-a) to correct factors associated with increased susceptibility.

Methods Wild-type mice and those with varying degrees of impairment of Fas (lpr) or Fas ligand signalling (gld) were challenged with Streptococcus pneumoniae and microbiological and immunological outcomes measured in the presence or absence of DcR3-a.

Results During established pneumonia, neutrophils became the predominant cell in the airway and gld mice were less able to clear bacteria from the lungs, demonstrating localised impairment of pulmonary neutrophil function in comparison to lpr or wild-type mice. T-cells from gld mice had enhanced activation and reduced apoptosis in comparison to wild-type and lpr mice during established pneumonia. Treatment with DcR3-a reduced T-cell activation and corrected the defect in pulmonary bacterial clearance in gld mice.

Conclusions The results suggest that imbalance in tumour necrosis factor superfamily signalling and excessive T-cell activation can impair bacterial clearance in the lung but that DcR3-a treatment can reduce T-cell activation, restore optimal pulmonary neutrophil function and enhance bacterial clearance during S pneumoniae infection.

    Research areas

  • FAS LIGAND, T-CELLS, IFN-GAMMA, STREPTOCOCCUS-PNEUMONIAE, FAS/FASL SYSTEM, APOPTOSIS, MICE, EXPRESSION, INFECTION, LIGHT

Download statistics

No data available

ID: 17164473